Robert J C Steele

Biography

Professor Robert Steele obtained his initial surgical and academic training in Edinburgh, Hong Kong and Aberdeen and was appointed as Senior Lecturer in Surgery at the University of Nottingham in 1990.  He was then appointed Professor of Surgical Oncology at the University of Dundee in 1996 and as Professor of Surgery and Head of Academic Surgery in 2003.  His main interests are the treatment of and screening for colorectal cancer. Having led the UK demonstration pilot that was used to inform the decision to introduce national screening programmes throughout the United Kingdom, he is at present the Clinical Director of the Scottish Colorectal Cancer Screening Programme, and has published extensively in this area. He has chaired several NHS QIS and HIS groups related to colorectal cancer and colorectal cancer screening and he chaired the SIGN group that developed the latest set of colorectal cancer guidelines.  He is a past member of Council of the Royal College of Surgeons of Edinburgh and current Editor of “The Surgeon”.  He is co-founder and co-director of the Scottish Cancer Prevention Network, Chair of the Health Improvement, Protection and Services (HIPS) Research Committee of the Scottish Government’s Chief Scientist’s Office, Chair of the Board of Directors of the Scottish Cancer Foundation and is a past President of the Association of Coloproctology of Great Britain and Ireland.  In 2016, he was appointed as Independent Chair of the UK National Screening Committee. In 2017 he was awarded an Honorary Membership of the Faculty of Public Health and was elected to the Fellowship of the Royal Society of Edinburgh.

Research Interest

His initial research interests were in breast cancer and, working for Professor Sir Patrick Forrest, he developed the concept of auxiliary node sampling.  In Hong Kong, his interest shifted to upper gastrointestinal disease and he was instrumental in developing and introducing endoscopic haemostasis for bleeding peptic ulcer.  In Nottingham, working for Professor Jack Hardcastle,  he became involved with the early trials of colorectal cancer screening and since then, colorectal cancer has remained his primary clinical and academic interest.  He has carried out work in surgery and radiotherapy for colorectal cancer and in the area of genetic and chromosomal abnormalities that underlie the disease.  His main research interest, however, is in colorectal cancer screening and he has published extensively in this area.